Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsSerradell, Marianela C
Rupil, Lucía L
Martino, Román A
Prucca, César G
Carranza, Pedro G
Fernández, Elmer A
Gargantini, Pablo R
Tenaglia, Albano H
Petiti, Juan P
Tonelli, Renata R
Luján, Hugo D
MetadataShow full item record
AbstractIntestinal and free-living protozoa, such as Giardia lamblia, express a dense coat of variant-specific surface proteins (VSPs) on trophozoites that protects the parasite inside the host's intestine. Here we show that VSPs not only are resistant to proteolytic digestion and extreme pH and temperatures but also stimulate host innate immune responses in a TLR-4 dependent manner. We show that these properties can be exploited to both protect and adjuvant vaccine antigens for oral administration. Chimeric Virus-like Particles (VLPs) decorated with VSPs and expressing model surface antigens, such as influenza virus hemagglutinin (HA) and neuraminidase (NA), are protected from degradation and activate antigen presenting cells in vitro. Orally administered VSP-pseudotyped VLPs, but not plain VLPs, generate robust immune responses that protect mice from influenza infection and HA-expressing tumors. This versatile vaccine platform has the attributes to meet the ultimate challenge of generating safe, stable and efficient oral vaccines.
AffiliationTWINCORE, Zentrum für experimentelle und klinische Infektionsforschung GmbH,Feodor-Lynen Str. 7, 30625 Hannover, Germany.
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
- Authors: Beljanski V, Chiang C, Kirchenbaum GA, Olagnier D, Bloom CE, Wong T, Haddad EK, Trautmann L, Ross TM, Hiscott J
- Issue date: 2015 Oct
- Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.
- Authors: Xue C, Tian G, Chen X, Liu Q, Ma J, Xu S, Li X, Chen H, Cao Y
- Issue date: 2015 Jan 2
- Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice.
- Authors: Ren Z, Zhao Y, Liu J, Ji X, Meng L, Wang T, Sun W, Zhang K, Sang X, Yu Z, Li Y, Feng N, Wang H, Yang S, Yang Z, Wang Z, Gao Y, Xia X
- Issue date: 2018 Sep 25
- Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
- Authors: Pascual E, Mata CP, Gómez-Blanco J, Moreno N, Bárcena J, Blanco E, Rodríguez-Frandsen A, Nieto A, Carrascosa JL, Castón JR
- Issue date: 2015 Mar
- Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
- Authors: Venereo-Sanchez A, Gilbert R, Simoneau M, Caron A, Chahal P, Chen W, Ansorge S, Li X, Henry O, Kamen A
- Issue date: 2016 Jun 17